Exagen Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| XGN | BDSX | IMDX | EDT.TO | CSTL | ICLR | |
|---|---|---|---|---|---|---|
| Market cap | 206.16M | 226.74M | 86.72M | 290.62M | 1.09B | 15.22B |
| P/E (TTM) | — | — | — | — | — | 81.2 |
| Forward P/E | -18.1 | -97.7 | -3.3 | 49.5 | -38.2 | 17.5 |
| Price/book | 16.9 | 24.8 | -4.1 | -4.1 | 2.3 | 1.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −19.26% | +175.87% | −59.23% | −31.25% | +6.56% | +26.94% |
| Today | +2.04% | +2.09% | −3.28% | +4.21% | +1.74% | −0.32% |
The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 15 min.
Latest news
All XGN news ›Financial Comparison: Hims & Hers Health (NYSE:HIMS) & Exagen (NASDAQ:XGN)
Posted by Defense World Staff on Oct 28th, 2026 Hims & Hers Health (NYSE:HIMS – Get Free Report) and Exagen (NASDAQ:XGN – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies…
Exagen Inc. (NASDAQ:XGN) Stock Has Average Target Price of $9.75
Posted by Tristan Rich on Oct 21st, 2026 Read Our Latest Stock Report on XGN Shares of XGN stock opened at $7.41 on Friday. The company has a quick ratio of 3.18, a current ratio of 3.18 and a debt-to-equity ratio of 1.96. The company has…
Centene (NYSE:CNC) vs. Exagen (NASDAQ:XGN) Head to Head Survey
Posted by Mitch Edgeman on Oct 14th, 2026 Exagen (NASDAQ:XGN – Get Free Report) and Centene (NYSE:CNC – Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- themarketsdaily.com2
- defenseworld.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.